采用直接法与间接法评估慢性鼻窦炎患者的健康效用值
本研究为横断面研究,纳入335例原发性慢性鼻窦炎患者,采用EQ-5D-5L、视觉模拟量表(VAS)、时间权衡法(TTO)和标准博弈法(SG)测量健康效用值(HUS)。总体HUS约为0.79-0.89,SNOT-22评分高、药物治疗失败、合并变应性鼻炎/哮喘、年龄大、内镜评分高和受教育程度低对HUS有负面影响,数据提示EQ-5D-5L可能是更优的测量方法。
要点
- EQ-5D-5L、VAS、TTO和SG测得的总体HUS分别为0.88±0.14、0.79±0.17、0.89±0.15和0.86±0.16。
- SNOT-22评分每增加1分,所有方法测得的HUS降低0.002至0.003(均p<0.01)。
- 计划行内镜鼻窦手术者在EQ-5D-5L和VAS上HUS较其他组低0.06至0.11(均p<0.05)。
核心结论
- 慢性鼻窦炎的总体HUS约为0.79-0.89。
- 高SNOT-22评分、药物治疗失败、合并变应性鼻炎/哮喘、年龄增加、高内镜评分和低受教育程度对HUS有负面影响。
- 数据提示EQ-5D-5L是测量慢性鼻窦炎患者HUS的更优方法。
研究设计与样本
- 横断面研究,招募原发性慢性鼻窦炎患者,评估临床和社会经济数据及HUS,比较四种方法测定的HUS评分。
- 共纳入335例患者。
主要发现
- EQ-5D-5L、VAS、TTO和SG测得的总体HUS分别为0.88±0.14、0.79±0.17、0.89±0.15和0.86±0.16。
- 多变量线性回归显示,SNOT-22评分每增加1分,所有方法测得的HUS降低0.002至0.003(均p<0.01)。
- 计划行内镜鼻窦手术者在EQ-5D-5L和VAS上HUS较其他组低0.06至0.11(均p<0.05)。
- 更高的内镜评分、年龄、合并气道疾病和较低受教育程度与较低HUS相关(p<0.05)。
- 基于HUS结果和回归模型,EQ-5D-5L可能是更优选择。
临床怎么用
- 作者认为,基于HUS结果和回归模型,EQ-5D-5L可能是测量慢性鼻窦炎患者HUS的更优方法。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
INTRODUCTION: EuroQol-5-dimensions-5-levels (EQ-5D-5L), visual analog scale (VAS), time trade-off (TTO), and standard gamble (SG) are used for the assessment of Health Utility Scores (HUS) of chronic rhinosinusitis (CRS). This study aimed to determine the overall HUS of CRS, the factors which influence the HUS, and the preferable method. METHODS: A cross-sectional study was conducted. Patients with primary CRS were recruited. Clinical and socioeconomic data together with HUS were assessed. Four HUS scores determined from the four different methods were compared. RESULTS: A total of 335 patients were enrolled. The overall HUS, as measured by EQ-5D-5L, VAS, TTO, and SG, was 0.88 ± 0.14, 0.79 ± 0.17, 0.89 ± 0.15, and 0.86 ± 0.16, respectively. The multivariable linear regression revealed that each increasing 22-item sinonasal outcome test (SNOT-22) score predicted a reduction of 0.002 to 0.003 in HUS (all methods, p < 0.01). Patients who scheduled for endoscopic sinus surgery had 0.06 to 0.11 HUS lower than other groups in EQ-5D-5L and VAS (all p < 0.05). Higher endoscopy score, age, presence of comorbid airway diseases, and lower education correlated with lower HUS (p < 0.05). Given the HUS results and regression models, the EQ-5D-5L is likely the preferable choice. CONCLUSION: The overall HUS of CRS was approximately 0.79-0.89. High SNOT-22 score and those who failed medications, presence of comorbid AR/asthma, increased age, high endoscopy score, and low education negatively impacted HUS. Our data suggest that EQ-5D-5L is a preferable method for measuring HUS in patients with CRS.
引用
- Chitsuthipakorn W, Pracharktam N, Phetpong J, et al. Evaluating health utility score through direct and indirect methods in patients with chronic rhinosinusitis. Int Forum Allergy Rhinol. 2024. PMID: 38555579. doi:10.1002/alr.23349
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。